Prof. Dr. Anja Katrin Boßerhoff

Lehrstuhl für Biochemie und Molekulare Medizin

Can checkpoint inhibitor therapy improve response to chemotherapy? (2018) Kirchberger MC, Schilling B, Haferkamp S, Boßerhoff AK, Schuler G, Heinzerling L Journal article MicroRNA-622 is a novel mediator of tumorigenicity in melanoma by targeting Kirsten rat sarcoma (2018) Dietrich P, Kuphal S, Spruss T, Hellerbrand C, Boßerhoff AK Journal article Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic "dual-hit" option (2018) Dietrich P, Freese K, Mahli A, Thasler WE, Hellerbrand C, Boßerhoff AK Journal article Selenium-binding protein 1 is down-regulated in malignant melanoma (2018) Schott M, de Jel MM, Engelmann JC, Renner P, Geissler EK, Boßerhoff AK, Kuphal S Journal article The importance of melanoma inhibitory activity gene family in the tumor progression of oral cancer (2018) Sasahira T, Boßerhoff AK, Kirita T Journal article Melanoma development: Molecular biology, genetics and clinical application (2017) Boßerhoff AK Authored book Clinicopathologic overview of melanoma (2017) Boßerhoff AK, Strizzi L Authored book MiRNAs in malignant melanoma (2017) Mione M, Liebig J, Munoz L, Boßerhoff AK Authored book UVB radiation represses CYLD expression in melanocytes (2017) Kuphal S, Schneider N, Massoumi R, Hellerbrand C, Boßerhoff AK Journal article Can checkpoint inhibitor therapy improve response to chemotherapy? (2017) Boßerhoff AK, Schuler G, Heinzerling L, Schilling B, Haferrkamp S, Kirchberger M Conference contribution, Conference Contribution